chronic myeloid leukemia: | multiple myeloma: | none hematopoitic metastases: المصحف بصوت محمد جبريل |
incidence, pathological features, associated syndromes and overall treatment of malignant small cell lung cancer by prof drs. RABBAB GAAFAR
Aromatase enzyme inhibitors, overview of st. gallen meeting, very important data about the biology and predictive factors of breast cancer by PROF. DRs. HEBA EL ZAWAHRY
inflamatory breast cancer incidence, biology, pathological features, suggested treatment options by PROF. DR. MAGDY SABER
Hepato-cellular carcinoma, incidence, biology, scoring systems different modalities of local and systemic treatment including new ara of target therapy by PROF. DR. MUSTAFA EL SERAFI
Acute myeloid leukemia presentation, diagnosis, classifications, new modalities of therapy and evidence based medicine by Dr. MOHAMED ABDEL MOOTI
NEW THE TEXT BOOK OF SURGICAL ONCOLOGY
EHA EDUCATION BOOK 2008
THE 10th INTERNATIONAL CONFERENCE ON PRIMARY THERAPY OF EARLY BREAST CANCER, 14 MARCH 2009, ST. GALLEN,
http://www.4shared.com/file/100071410/d71096bb/ST_GALLEN_SWITZERLAND_14_17_MARCH_2009.html

AnnalsOfOncology_Volume20_No2_February2009 AnnalsOfOncology_Volume20_No3_March2009
AnnalsOfOncology_Volume20_No4_April2009 http://rapidshare.com/files/33346053/AJCC_Cancer_staging.pdf http://rapidshare.com/files/199180745/wcr_2008.pdf Transplantation Drug Manual Clinician Pocket Drug Referencel Manual Of Pharmacology
Annals Of Oncology
AnnalsOfOncology_Volume20_No1_January2009
NEW AnnalsOfOncology_Volume20_No5_May2009
Oncology: An Evidence-Based Approach
http://www.4shared.com/file/100057411/ffbcaa91/Oncology_-_An_Evidence-Based_Approach__Springer_2005_.html

1. von-hipple lindu disease: by dr Alfred Elias, (VHL.ppt),
2. thalidomide an old and new drug: by dr Ehab Mosaad ( thalidomide.ppt ).
3. Incidence, epidemiology, staging, and new modalities of therapy of oseosarcoma by dr. AMIRA DIAA (osteogenic sarcoma.ppt)
4. neoadjuvant chemotherapy for localy advanced ovarian cancer, is it important, evidence based, and beneficial, an overview by dr AHMAD MUSTAFA lecturer of onco-surgery in the NATIONAL CANCER INSTITUTE